Eton Pharmaceuticals

Eton Pharmaceuticals

Focused on the development and commercialization of innovative sterile injectable product candidates utilizing. Learn more

Launch date
Employees
Market cap
AUD192m
Enterprise valuation
AUD172m (Public information from Sep 2024)
Deer Park Illinois (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD2019202020212022202320242025
Revenues<1m<1m21.8m21.3m31.6m36.5m47.4m
% growth(95 %)(96 %)55879 %(3 %)49 %15 %30 %
EBITDA(18.2m)(26.5m)(1.0m)(6.5m)(<1m)(2.3m)7.1m
% EBITDA margin(1893 %)(67846 %)(5 %)(31 %)(1 %)(6 %)15 %
Profit(18.3m)(28.0m)(2.0m)(9.0m)(<1m)(3.8m)5.6m
% profit margin(1910 %)(71718 %)(9 %)(42 %)(3 %)(10 %)12 %
EV / revenue133.7x5048.7x4.8x3.4x3.5x3.3x2.5x
EV / EBITDA-7.1x-7.4x-102.2x-11.0x-386.3x-51.6x16.7x
R&D budget11.6m14.1m6.2m4.0m3.3m--
R&D % of revenue1205 %36164 %29 %19 %10 %--
  • Edit
DateInvestorsAmountRound
-

N/A

-
N/A

$20.0m

Series A
N/A

$22.0m

Valuation: $102m

IPO
N/A

$7.5m

Post IPO Equity
*

N/A

Post IPO Equity
*

$10.6m

Post IPO Equity
Total FundingAUD30.9m

Recent News about Eton Pharmaceuticals

Edit
More about Eton Pharmaceuticalsinfo icon
Edit

Eton Pharmaceuticals is a specialty pharmaceutical company dedicated to advancing healthcare by developing and commercializing innovative medicines that are both affordable and accessible to all patients. The company focuses on creating proprietary formulations of approved molecules, aiming to improve existing treatments by making them safer, more effective, or less expensive. Eton Pharmaceuticals serves a diverse range of clients, including healthcare providers and patients, primarily within the pharmaceutical and healthcare markets. The business model revolves around continuous product development and portfolio expansion, ensuring a steady pipeline of new and improved medications. Revenue is generated through the commercialization of these proprietary formulations, which are designed to meet unmet medical needs and offer significant improvements over existing products.

Keywords: specialty pharmaceuticals, innovative medicines, proprietary formulations, healthcare, affordable treatments, patient care, product development, portfolio expansion, safer medications, effective treatments.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.